Polymeric Nanoformulation of Zoledronic Acid Rescues Osteoblasts from the Harmful Effect of its Native Form: An In Vitro Investigation of Cytotoxic Potential on Osteoblasts and Osteosarcoma Cells
Authors:
- 10 July 2023
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 23 (11) , e2300211
Abstract
Osteosarcoma (OS) is a malignant tumor, fatal for pediatric patients who do not respond to chemotherapy, alternative therapies and drugs can provide better outcomes. Zoledronic acid (Zol) belonging to the class of bisphosphonates (BPs) has a direct antitumor ability to prevent Ras GTPases modification and stimulate apoptosis. Despite advances in maintaining balance in skeletal events and direct anticancer properties, Zol causes cytotoxicity to normal healthy pre‐osteoblast cells, hampering mineralization and differentiation. The study reports the preparation and evaluation of a nanoformulation that can diminish the existing drawbacks of native Zol. The cytotoxic effect is evaluated on bone cancer cells and healthy bone cells with three different cell lines namely, K7M2 (mouse OS cell line), SaOS2 (human OS cell line), and MC3T3E1 (healthy cell counterpart). It is observed that Zol nanoformulation is uptaken more (95%) in K7M2 whereas in MC3T3E1, the percent population internalizing nanoparticles (NPs) is 45%. Zol has a sustained release of 15% after 96 h from the NP which leads to a rescuing effect on the normal pre‐osteoblast cells. In conclusion, it can be stated that Zol nanoformulation can be used as a good platform for a sustained release system with minimum side effects to normal bone cells.Keywords
This publication has 17 references indexed in Scilit:
- Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood CellsPLOS ONE, 2014
- Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKLJournal of Bone and Mineral Research, 2014
- Acidic tumor microenvironment and pH-sensing G protein-coupled receptorsFrontiers in Physiology, 2013
- Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cellsBiochemical Pharmacology, 2013
- Biodegradation and biocompatibility of PLA and PLGA microspheresAdvanced Drug Delivery Reviews, 2012
- Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?Diagnostic Pathology, 2012
- A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticlesJournal of Controlled Release, 2009
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosisExperimental Cell Research, 2007
- Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophagesJournal of Bone and Mineral Research, 1987